Eye Care Blog

ZEST Treatment

woman's blue eye close up

Proper eyelid cleanliness considerably decreases the symptoms of dry eye. Zest treatment provides a highly effective, but delicate exfoliation of the eyelids, as well as a thorough cleansing.

ZEST (Zocular Eyelid System Treatment) is an okra-based solution applied with a micro sponge applicator to softly exfoliate any dead cells, debris, or biofilms that accumulate on the lid margins and contribute to inflammation, infection, or irritation.

ZEST is like a shampoo for the eyes, in that it cleans the lids and the eyelashes (and even lathers!). ZEST gel is applied to the edge of the eyelids and lashes, and then massaged into a lather with a gentle circular motion.

Once the eyes are washed, a saline solution removes the gel. ZEST gel is produced with a refined extract of okra (an edible green seed pod), and works to lift and clean oil, debris, and residue along the eyelid edge. The polysaccharides found in okra plants are a gentle and effective cleanser.

The ZEST Method

ZEST was created as a therapy for blepharitis. The straightforward and painless method that it uses, known as an eyelid debridement operation, exfoliates the eyelids and opens up the meibomian glands. As a result, oils can be released into the eye, which increases the formation of healthy tears and lessens dry eye symptoms.

Who is a good candidate for ZEST?

Patients who suffer from blepharitis, Demodex mites, dry eye, meibomian gland dysfunction (MGD), patients who use contact lenses, pre-surgical patients, eyelash extension wearers, and patients who have frequent styes are good candidates for this treatment. If dry eye particularly is an ongoing issue, there are several other treatments to consider.

Share this post
WhatsApp
Email
Facebook
Twitter
LinkedIn
Recent blog posts
woman's blue eye close up

ZEST Treatment

Proper eyelid cleanliness considerably decreases the symptoms of dry eye. Zest treatment provides a highly effective, but delicate exfoliation of the eyelids, as well as

Read More »